Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 426.60 1.32
Hindalco 144.70 0.00
Bhel 189.30 1.42
Larsen & 1377.30 2.48
Wipro Lt 525.00 1.19
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-J B Chemicals & Pharmaceuticals Limited
J B Chemicals & Pharmaceuticals Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:506943NSE:JBCHEPHARMBloomberg:JBCP@INReuters:JBCH.BO
Market Lot: 1Face Value: 2ISIN Demat: INE572A01028
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
06-JAN-14 J B Chemicals & Pharmaceuticals said that the compensation committee of the board of directors of the company has today issued and allotted 19,825 equity shares of face value of Rs 2 each (10,500 shares at a premium of Rs 82 per share and 9,325 shares at a premium of Rs 93 per share) to certain employees against the exercise of options granted to them pursuant to employees stock option scheme of the company. 31-OCT-13 J B Chemicals &...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
JB Chemicals receives USFDA approval for Tinidazole  -IRIS 22-Oct-13
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2013(9)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 7108.287944.616357.75
Other Income291.69259.61285.12
Total Income7399.978204.226642.87
Cost of goods sold5956.067116.856069.50
OPBDIT1443.911087.37573.37
PAT469.93849.396426.99
Gross Block---
Equity capital169.42169.42169.42
EPS (Rs.)-10.0375.95
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-5.88 - 9.610.76 - 2.44
Debt / Equity (x)---
Operating margin (% of OI)19.513.3 8.6
Net margin (% of OI) 6.410.496.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Neelam Centre
B Wing, 4th Floor
Hind Cycle Road
Worli
Mumbai
Maharashtra-400 030
PHONE
(022) 3045 1200/ 1500
FAX
(022) 2493 0534/ 9633
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer